Kimer Med
PrivateLast Round
Series A
Oct 1, 2024
Total Funding Raised
$11.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kimer Med operates in Healthcare & Life Sciences and is based in Nelson. Its latest recorded funding round was a Series A round in October 2024.
Kimer Med is a biotechnology company that develops broad-spectrum antiviral therapeutics to treat viral diseases and support pandemic preparedness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kimer Med Comparables
Compare Kimer Med with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evrys Bio | 82% | |
| NanoViricides, Inc. | 76% | |
| Avocet Bio GmbH | 74% |
For institutional investors. Book with your work email.
Kimer Med Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 1, 2024 | ||||
| Seed | Mar 31, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kimer Med Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seed The Change | He Kākano Hāpai | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 90% MoM.
- May 18, 2026
Monthly visitors increased 123% MoM.
For institutional investors. Book with your work email.
Kimer Med Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kimer Med's valuation, stock price, and market status.
Is Kimer Med a public or private company?
Kimer Med is a private company.
What is the current stock price of Kimer Med?
Kimer Med is a private company, so its shares have no public market price. Caplight tracks Kimer Med's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kimer Med worth (valuation)?
Valuation information for Kimer Med is not publicly available.
Can I buy Kimer Med stock?
Kimer Med shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kimer Med's last funding round?
Kimer Med's most recent funding round was Series A on October 1, 2024.
Who are the main investors in Kimer Med?
Key investors in Kimer Med include Seed The Change | He Kākano Hāpai.
Will Kimer Med IPO soon?
No public IPO plans have been announced for Kimer Med.
How can I track Kimer Med secondary market activity?
Caplight tracks bids, offers, and trades in Kimer Med's shares on secondary markets.